Vanda Pharmaceuticals Stock Surges Following the Launch of the First Motion Sickness Drug in 40 Years

Washington, Monday, 4 May 2026.
Vanda Pharmaceuticals’ stock surged after launching NEREUS on May 1, 2026. As the first new motion sickness drug in 40 years, it features an innovative direct-to-consumer pricing model.